Ivermectin for covid 19

way 2 go

Well-known member
.https://twitter.com/CKellyUAP/status/1709188666894299463
How many Australians died because of the stupidity and ignorance of Albanese & Bowen who ignored the science and rubbished Hydroxychloroquine on the floor of the Australian Parliament ? Both Albanese & Bowen have blood on their hands. At the next sitting of Federal Parliament Albanese & Bowen must apologise to the Australian people and to the families that lost love ones to Covid that were denied access to Hydroxychloroquine..



Retrospective study of 3,885 hospitalized COVID-19 patients in Belgium showing significantly lower mortality with HCQ treatment. Patients that didn’t receive Hydroxychloroquine had a 57% greater chance of dying. Authors state; treatment was found to be associated with a statistically significant 36,5% reduction of mortality. This survival benefit was present across all age groups and remained significant after adjustment for comorbid conditions and disease severity upon admission. This result is remarkable because treatment with hydroxychloroquine was abandoned following the results of the SOLIDARITY and RECOVERY trial, which did not find a clinical benefit [20,21]. Our results are in accordance with several observational trials and large case series reporting survival benefit in patients treated with hydroxychloroquine [12], [[23], [24], [25], [26], [27], [28], [29]]. Other studies found no benefit, but often reserved treatment for severely ill patients [18,19,30]. A potential explanation for the discrepancy between the results in the observational trials and the large randomized trials may be the use of a different dose of hydroxychloroquine. And conclude; Treatment of COVID-19 using a combination of hydroxychloroquine plus azithromycin was safe and was associated with a statistically significant mortality benefit in the treatment of COVID-19 infection in hospitalized patients.

Volume 55, October 2023, 101172
Image
 

way 2 go

Well-known member
.https://vigilantnews.com/post/this-nobel-prize-winning-drug-is-now-quietly-under-attack-its-not-hydroxychloroquine-or-ivermectin

“In China, Novartis works with about 100,000 farmers who cultivate Artemisia Annua, a crucial plant in the production of our antimalarial treatment.”
 

Idolater

Popetard
I trust Rogan Ben Shapiro Tucker Carlson

I was going to say I trust them more than the mainstream media but I don't trust the mainstream media at all. You lie to me once and I'm never going to trust you again and they've been caught lying over and over and over again
Which means it's poker. Is there a game where lying is integral? Yes, poker. You don't trust lies, but you do trust chip movement. Nobody makes big bets holding nothing, unless they're bluffing or they're idiots. If you have a strong hand, you can afford to call their big bets and see.
 

way 2 go

Well-known member


I often quip about “covid miracles”— the occasional unexpected and often surprising blessings flowing from the pandemic. This might be the biggest covid miracle of them all. Some of our heroic pandemic docs have managed to publish a peer-reviewed study in a mainstream journal suggesting a potentially staggering 85% benefit for cancer patients taking a combination of two cheap, safe anti-parasitic drugs: ivermectin and mebendazole. The study’s title: Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort.

image.png

Let’s start with the disclaimers. This was not a “gold standard” clinical trial. The 122 participants were telemedicine patients who self-reported their status during the study period. No placebos, randomization, or double-blinding were used. The results can’t be compared to a control group that didn’t take the ivermectin combo.

The participants were health-motivated, self-selected cancer victims who were also trying various other things at the same time, like supplements, chemo, radiation, keto diets, fasting, etc. They were all at different stages of their oncology; some with new-onset disease, some having survived 5+ years.

...

It would be one thing if the study patients had reported a minor benefit. But the magnitude and consistency of the self‑reported “clinical benefit” signal was so large that, even through heavy noise and bias, it still plausibly indicates a real underlying effect worth taking very seriously and testing rigorously.

image 4.png

At six months, fully a third (33%) of respondents remarkably reported “no current evidence of disease” (NED). 16% reported regression, and another third (36%) reported stabilized disease, for a combined and stunning “clinical benefit ratio” (CBR) of 84% (with a 95% confidence interval of 77‑90%).

...

This study is not about “this proves ivermectin + mebendazole works.” Rather, the size, internal consistency, and biological plausibility of the observed signal, in a relatively large and diverse real‑world study group, raise a credible possibility —if not probability— of true anticancer activity that justifies urgent, independent, randomized, controlled trials, and cannot be casually waved away.
 
Top